Defining the Specificity Space of the Human Src Homology 2 Domain*S

Src homology 2 (SH2) domains are the largest family of interaction modules encoded by the human genome to recognize tyrosine-phosphorylated sequences and thereby play pivotal roles in transducing and controlling cellular signals emanating from protein-tyrosine kinases. Different SH2 domains select for distinct phosphopeptides, and the function of a given SH2 domain is often dictated by the specific motifs that it recognizes. Therefore, deciphering the phosphotyrosyl peptide motif recognized by an SH2 domain is the key to understanding its cellular function. Here we cloned all 120 SH2 domains identified in the human genome and determined the phosphotyrosyl peptide binding properties of 76 SH2 domains by screening an oriented peptide array library. Of these 76, we defined the selectivity for 43 SH2 domains and refined the binding motifs for another 33 SH2 domains. We identified a number of novel binding motifs, which are exemplified by the BRDG1 SH2 domain that selects specifically for a bulky, hydrophobic residue at P + 4 relative to the Tyr(P) residue. Based on the oriented peptide array library data, we developed scoring matrix-assisted ligand identification (or SMALI), a Web-based program for predicting binding partners for SH2-containing proteins. When applied to SH2D1A/SAP (SLAM-associated protein), a protein whose mutation or deletion underlies the X-linked lymphoproliferative syndrome, SMALI not only recapitulated known interactions but also identified a number of novel interacting proteins for this disease-associated protein. SMALI also identified a number of potential interactors for BRDG1, a protein whose function is largely unknown. Peptide in-solution binding analysis demonstrated that a SMALI score correlates well with the binding energy of a peptide to a given SH2 domain. The definition of the specificity space of the human SH2 domain provides both the necessary molecular basis and a platform for future exploration of the functions for SH2-containing proteins in cells.

[1]  L. Cantley,et al.  Recognition and specificity in protein tyrosine kinase-mediated signalling. , 1995, Trends in biochemical sciences.

[2]  P. Heinrich,et al.  The Jak1 SH2 Domain Does Not Fulfill a Classical SH2 Function in Jak/STAT Signaling but Plays a Structural Role for Receptor Interaction and Up-regulation of Receptor Surface Expression* , 2005, Journal of Biological Chemistry.

[3]  T. Pawson,et al.  Reading protein modifications with interaction domains , 2006, Nature Reviews Molecular Cell Biology.

[4]  S. Harrison,et al.  Recognition of a high-affinity phosphotyrosyl peptide by the Src homology-2 domain of p56lck , 1993, Nature.

[5]  W. Lim,et al.  Domains, motifs, and scaffolds: the role of modular interactions in the evolution and wiring of cell signaling circuits. , 2006, Annual review of biochemistry.

[6]  I. Campbell,et al.  Structure of an SH2 domain of the p85α subunit of phosphatidylinositol-3-OH kinase , 1994, Nature.

[7]  Bissan Al-Lazikani,et al.  Sequence, structure and energetic determinants of phosphopeptide selectivity of SH2 domains. , 2003, Journal of molecular biology.

[8]  M. Nei,et al.  MEGA4: Molecular Evolutionary Genetics Analysis (MEGA) software version 4.0. , 2007, Molecular biology and evolution.

[9]  D. Pei,et al.  Determination of the binding specificity of the SH2 domains of protein tyrosine phosphatase SHP-1 through the screening of a combinatorial phosphotyrosyl peptide library. , 2000, Biochemistry.

[10]  S. Latour,et al.  The SAP family of adaptors in immune regulation. , 2004, Seminars in immunology.

[11]  S. Lo,et al.  Platelet-derived Growth Factor-induced Formation of Tensin and Phosphoinositide 3-Kinase Complexes* , 1996, The Journal of Biological Chemistry.

[12]  滋郎 中島.  海外文献紹介：Nck adaptor proteins link nephrin to the actin cytoskeleton of kidney podocytes , 2006 .

[13]  R. Frank.  The SPOT-synthesis technique. Synthetic peptide arrays on membrane supports--principles and applications. , 2002, Journal of immunological methods.

[14]  Douglas J Hilton,et al.  SH2 domains from suppressor of cytokine signaling-3 and protein tyrosine phosphatase SHP-2 have similar binding specificities. , 2002, Biochemistry.

[15]  S. Hubbard,et al.  Structural basis for phosphotyrosine recognition by suppressor of cytokine signaling-3. , 2006, Structure.

[16]  J. Darnell,et al.  Crystal Structure of a Tyrosine Phosphorylated STAT-1 Dimer Bound to DNA , 1998, Cell.

[17]  Frank McCormick,et al.  Nonsense mutations in the C–terminal SH2 region of the GTPase activating protein (GAP) gene in human tumours , 1993, Nature Genetics.

[18]  T. Pawson,et al.  A mammalian adaptor protein with conserved Src homology 2 and phosphotyrosine-binding domains is related to Shc and is specifically expressed in the brain. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[19]  Michael C. Ostrowski,et al.  Tyrosine kinase Etk/BMX is up-regulated in human prostate cancer and its overexpression induces prostate intraepithelial neoplasia in mouse. , 2006, Cancer research.

[20]  Lewis C Cantley,et al.  A rapid method for determining protein kinase phosphorylation specificity , 2004, Nature Methods.

[21]  D. Baltimore,et al.  Three-dimensional solution structure of the src homology 2 domain of c-abl , 1992, Cell.

[22]  Maciej J. Swat,et al.  Cytoskeletal remodeling in lymphocyte activation. , 2003, Current opinion in immunology.

[23]  Junguk Park,et al.  Decoding protein-protein interactions through combinatorial chemistry: sequence specificity of SHP-1, SHP-2, and SHIP SH2 domains. , 2005, Biochemistry.

[24]  S. Carroll,et al.  Evolution of Key Cell Signaling and Adhesion Protein Families Predates Animal Origins , 2003, Science.

[25]  Markus H. Heim,et al.  Characterization of Phosphopeptide Motifs Specific for the Src Homology 2 Domains of Signal Transducer and Activator of Transcription 1 (STAT1) and STAT3* , 2003, The Journal of Biological Chemistry.

[26]  T Pawson,et al.  Src homology region 2 domains direct protein-protein interactions in signal transduction. , 1990, Proceedings of the National Academy of Sciences of the United States of America.

[27]  Michael B. Yaffe,et al.  Scansite 2.0: proteome-wide prediction of cell signaling interactions using short sequence motifs , 2003, Nucleic Acids Res..

[28]  T Pawson,et al.  Structural basis for specificity switching of the Src SH2 domain. , 2000, Molecular cell.

[29]  S. Lo,et al.  The phosphotyrosine-independent interaction of DLC-1 and the SH2 domain of cten regulates focal adhesion localization and growth suppression activity of DLC-1 , 2007, The Journal of cell biology.

[30]  Kazuya Machida,et al.  The SH2 domain: versatile signaling module and pharmaceutical target. , 2005, Biochimica et biophysica acta.

[31]  T Pawson,et al.  SH2 and SH3 domains: elements that control interactions of cytoplasmic signaling proteins. , 1991, Science.

[32]  Joseph Schlessinger,et al.  SH2 and PTB Domains in Tyrosine Kinase Signaling , 2003, Science's STKE.

[33]  Nikolaj Blom,et al.  Phospho.ELM: A database of experimentally verified phosphorylation sites in eukaryotic proteins , 2004, BMC Bioinformatics.

[34]  Y. Zhang,et al.  IntAct—open source resource for molecular interaction data , 2006, Nucleic Acids Res..

[35]  M. Yaffe,et al.  Biochemical Interactions Integrating Itk with the T Cell Receptor-initiated Signaling Cascade* , 2000, The Journal of Biological Chemistry.

[36]  C. Vetriani,et al.  Modified phage peptide libraries as a tool to study specificity of phosphorylation and recognition of tyrosine containing peptides. , 1997, Journal of molecular biology.

[37]  S. Li,et al.  The role of SLAM family receptors in immune cell signaling. , 2006, Biochemistry and cell biology = Biochimie et biologie cellulaire.

[38]  P. Bork,et al.  Systematic Discovery of In Vivo Phosphorylation Networks , 2007, Cell.

[39]  R. Evans,et al.  The Spt6 SH2 domain binds Ser2-P RNAPII to direct Iws1-dependent mRNA splicing and export. , 2007, Genes & development.

[40]  B. Mayer,et al.  Binding of transforming protein, P47gag-crk, to a broad range of phosphotyrosine-containing proteins. , 1990, Science.

[41]  S. Shoelson,et al.  Crystal Structure of the Tyrosine Phosphatase SHP-2 , 1998, Cell.

[42]  M. Moran,et al.  Binding of SH2 domains of phospholipase C gamma 1, GAP, and Src to activated growth factor receptors. , 1990, Science.

[43]  T. Denning,et al.  Negative regulation of T cell activation and autoimmunity by the transmembrane adaptor protein LAB. , 2006, Immunity.

[44]  U. Ikeda,et al.  Molecular cloning of a docking protein, BRDG1, that acts downstream of the Tec tyrosine kinase. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[45]  R. Aebersold,et al.  The Direct Recruitment of BLNK to Immunoglobulin α Couples the B-Cell Antigen Receptor to Distal Signaling Pathways , 2002, Molecular and Cellular Biology.

[46]  J. Naismith,et al.  Crystal structure of the tyrosine phosphatase Cps4B from Steptococcus pneumoniae TIGR4 in complex with phosphate. , 2009 .

[47]  I. Jurisica,et al.  Unequal evolutionary conservation of human protein interactions in interologous networks , 2007, Genome Biology.

[48]  T Pawson,et al.  Specific motifs recognized by the SH2 domains of Csk, 3BP2, fps/fes, GRB-2, HCP, SHC, Syk, and Vav , 1994, Molecular and cellular biology.

[49]  D. Allen,et al.  The X-linked lymphoproliferative-disease gene product SAP regulates signals induced through the co-receptor SLAM , 1998, Nature.

[50]  G. Crooks,et al.  WebLogo: a sequence logo generator. , 2004, Genome research.

[51]  T. Pawson,et al.  The human and mouse complement of SH2 domain proteins-establishing the boundaries of phosphotyrosine signaling. , 2006, Molecular cell.

[52]  D. Baltimore,et al.  Crystal structure of the phosphotyrosine recognition domain SH2 of v-src complexed with tyrosine-phosphorylated peptides , 1993, Nature.

[53]  Tony Pawson,et al.  A ‘three‐pronged’ binding mechanism for the SAP/SH2D1A SH2 domain: structural basis and relevance to the XLP syndrome , 2002, The EMBO journal.

[54]  A. Alcover,et al.  Vav proteins, masters of the world of cytoskeleton organization. , 2004, Cellular signalling.

[55]  Michael A. Patton,et al.  Mutations in PTPN11, encoding the protein tyrosine phosphatase SHP-2, cause Noonan syndrome , 2001, Nature Genetics.

[56]  Rui Xu,et al.  Construction of A Non-Redundant Human SH2 Domain Database , 2004, Genomics, proteomics & bioinformatics.

[57]  D. Baltimore,et al.  The noncatalytic src homology region 2 segment of abl tyrosine kinase binds to tyrosine-phosphorylated cellular proteins with high affinity. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[58]  T. D. Schneider,et al.  Sequence logos: a new way to display consensus sequences. , 1990, Nucleic acids research.

[59]  J. Darnell,et al.  Structural bases of unphosphorylated STAT1 association and receptor binding. , 2005, Molecular cell.

[60]  T. Pawson,et al.  Nuclear magnetic resonance structure of an SH2 domain of phospholipase C-γ1 complexed with a high affinity binding peptide , 1994, Cell.

[61]  S. Li,et al.  An Oriented Peptide Array Library (OPAL) Strategy to Study Protein-Protein Interactions* , 2004, Journal of Biological Chemistry.

[62]  T. Hunter,et al.  The Protein Kinase Complement of the Human Genome , 2002, Science.

[63]  T. Pawson,et al.  SH2 domains recognize specific phosphopeptide sequences , 1993, Cell.

[64]  T Pawson,et al.  A noncatalytic domain conserved among cytoplasmic protein-tyrosine kinases modifies the kinase function and transforming activity of Fujinami sarcoma virus P130gag-fps , 1986, Molecular and cellular biology.

[65]  Gianni Cesareni,et al.  Normalization of nomenclature for peptide motifs as ligands of modular protein domains , 2002, FEBS letters.